Wednesday, May 30, 2018 11:39:35 AM
MINNEAPOLIS, May 17, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (PETV), (www.petvivo.com) an emerging biomedical device company, is happy to announce that for the first time commercial product is available and the sales force is commencing sales efforts in the form of a soft rollout covering eleven states.
The Kush™ System has been produced, packaged and ready to ship from its production facility and production partner Elite Solutions, in Rochester, Minnesota. Several notable veterinarians that have been involved with the Kush™ System have been waiting months to order. The day has finally come that an extended treatment for Osteoarthrosis for Canine and Equine is available. The company is expecting immediate sales.
Wes Hayne, CEO, stated, “It has taken nearly a year to accomplish the final phases leading up to finished product. Phase I of the rollout is eleven states. We estimate phase II to commence within four to six months adding an additional five states.”
For Phase I, the company has contracted independent distributors covering Minnesota, North Dakota, South Dakota, Wisconsin, Nebraska, Iowa, Kansas, Ohio, Kentucky, Arizona, and New Mexico. Additional markets will be added as the rollout continues. The company is reviewing additional distribution as part of Phase II in Texas, Oklahoma, California, Florida, and New York.
PetVivo is preparing to attend and present at a series of trade shows and veterinarian conferences. Marketing and educational materials are being prepared. Educational material will appear in a couple of weeks on the website which has a major facelift underway. The unveiling of the site should be in 2-3 weeks.
It is a very exciting time for PetVivo Holdings, Inc. We want to continue to thank all our shareholders and associates who have supported us through some very difficult times to this point of celebration.
(All Press Releases Will Be Available for Viewing on Facebook or the Web at www.petvivo.com)
About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (PETV) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets and pet therapeutics. PetVivo is leveraging investments made in the human medical device industry to commercialize therapeutics for pets in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.
PetVivo's strategy is to commercialize proprietary products from human medical device companies specifically for the companion animal market. The company’s product pipeline includes seventeen animal and human therapeutics. A portfolio of twenty patents protects the company’s products, production processes and biomaterials. PetVivo’s lead product, a veterinarian-administered joint injection for the treatment of osteoarthritis in dogs, is scheduled for launch later this year.
Forward-Looking commercial Statements:
The foregoing material may contain forward-looking statements. We caution that such statements may be subject to uncertainties and that actual results could differ materially from the forward-looking statements. Readers accordingly should not place undue reliance on these forward-looking statements, which do not reflect unknown or unanticipated events or circumstances occurring after the date of these forward-looking statements.
CONTACT:
Wes Hayne
CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
Main: 962-405-6216F
Direct: (763) 443-7272F
Recent PETV News
- PetVivo Taps Top Sales Executive, Skylor Walker, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide • GlobeNewswire Inc. • 09/16/2024 12:00:00 PM
- PetVivo’s Spryng with OsteoCushion™ Technology Featured in Visionaries on Bloomberg TV • GlobeNewswire Inc. • 09/12/2024 12:00:00 PM
- PetVivo Meets Growing Demand for Spryng™ with Appointment of Veterinary Surgeon, Kirsty Husby, as Senior Technical Services Veterinarian • GlobeNewswire Inc. • 09/09/2024 02:22:00 PM
- Scot Cave Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager • GlobeNewswire Inc. • 09/03/2024 02:27:00 PM
- PetVivo Teams with Orthobiologic Innovations for Clincial Research and Product Commercialization • GlobeNewswire Inc. • 08/27/2024 12:00:00 PM
- Anthony Germinaro Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager • GlobeNewswire Inc. • 08/19/2024 02:10:00 PM
- PetVivo Reports Reports Fiscal Q1 2025 Results • GlobeNewswire Inc. • 08/14/2024 08:25:00 PM
- Eric Samples Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager • GlobeNewswire Inc. • 08/12/2024 05:52:00 PM
- PetVivo Sets Fiscal First Quarter 2025 Conference Call for Wednesday, August 14 at 5:00 p.m. ET • GlobeNewswire Inc. • 08/08/2024 02:25:00 PM
- PetVivo Reports Reports Fiscal 2024 Results • GlobeNewswire Inc. • 06/28/2024 08:41:38 PM
- PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET • GlobeNewswire Inc. • 06/25/2024 08:15:22 PM
- PetVivo Appoints Former NOVUS and Colgate-Palmolive Senior Sales & Marketing Executive, Bryan Monninger, as VP of Sales • GlobeNewswire Inc. • 06/06/2024 11:00:00 AM
- April Boyce Joins PetVivo Holdings, Inc. as the Vice President of Marketing • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA • GlobeNewswire Inc. • 04/08/2024 10:30:00 AM
- PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA • GlobeNewswire Inc. • 04/03/2024 01:25:00 PM
- PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 02:19:16 PM
- Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- New to The Street Announces its Five Corporate TV Interviews, Airing Episode 561 on the FOX Business Network Monday, March 11, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 03/08/2024 02:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/07/2024 10:19:48 PM
- New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT • GlobeNewswire Inc. • 03/07/2024 02:37:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 08:54:02 PM
- PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- New to The Street Announces its Line-up, Four Corporate Interviews Airings on The FOX Business Network, Monday, March 4, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 03/01/2024 02:30:00 PM
- Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM